Skip to main content

Table 1 Characteristics of the two study cohorts according to the case volume strata

From: Institutional case volume and mortality after aortic and mitral valve replacement: a nationwide study in two Korean cohorts

 

Aortic valve replacement (n = 7875)

Mitral valve replacement (n = 5084)

Low-volume (< 20 cases/year)

Medium-volume (20–70 cases/year)

High-volume (> 70 cases/year)

P

Low-volume (< 15 cases/year)

Medium-volume (15–40 cases/year)

High-volume (> 40 cases/year)

P

No. of patients

2318

2102

3455

 

1663

1501

1920

 

Age (years)

66 (12)

67 (12)

67 (12)

 < 0.001

60 (13)

59 (13)

58 (12)

0.001

Female

939 (40%)

848 (40%)

1446 (42%)

0.442

912 (55%)

899 (60%)

1259 (66%)

 < 0.001

Hypertension

1500 (65%)

1388 (66%)

2319 (67%)

0.165

983 (59%)

919 (61%)

1182 (62%)

0.280

Dyslipidaemia

761 (33%)

624 (30%)

1248 (36%)

 < 0.001

332 (20%)

249 (17%)

362 (19%)

0.046

Diabetes mellitus

482 (21%)

446 (21%)

647 (19%)

0.041

211 (13%)

188 (13%)

212 (11%)

0.251

Extracardiac arteriopathy

353 (15%)

330 (16%)

489 (14%)

0.250

207 (12%)

174 (12%)

162 (8%)

 < 0.001

Chronic lung disease

1002 (43%)

918 (44%)

1403 (41%)

0.040

707 (43%)

680 (45%)

788 (41%)

0.042

Renal impairment

59 (3%)

64 (3%)

79 (2%)

0.222

33 (2%)

23 (2%)

13 (1%)

0.003

Atrial fibrillation

228 (10%)

183 (9%)

313 (9%)

0.403

689 (41%)

683 (46%)

1115 (58%)

 < 0.001

Angina pectoris

898 (39%)

819 (39%)

1378 (40%)

0.638

375 (23%)

339 (23%)

416 (22%)

0.765

Recent myocardial infarction*

69 (3%)

54 (3%)

68 (2%)

0.045

37 (2%)

34 (2%)

25 (1%)

0.058

Congestive heart failure

548 (24%)

510 (24%)

749 (22%)

0.054

551 (33%)

519 (35%)

601 (31%)

0.129

Urgent or emergent surgery

59 (3%)

35 (2%)

25 (1%)

 < 0.001

60 (4%)

43 (3%)

23 (1%)

 < 0.001

Red blood cell transfusion, units

2 (2–3)

2 (2–3)

3 (2–4)

 < 0.001

3 (2–4)

2 (2–4)

2 (1–3)

 < 0.001

Aortic valve diagnosis

   

 < 0.001

NA

  Stenosis

1360 (59%)

1238 (59%)

1968 (57%)

 

NA

  Insufficiency

491 (21%)

455 (22%)

732 (21%)

 

NA

  Stenoinsufficiency

289 (12%)

287 (14%)

622 (18%)

 

NA

  Not specified

178 (8%)

122 (6%)

133 (4%)

 

NA

Concurrent CABG

309 (13%)

353 (17%)

613 (18%)

 < 0.001

NA

Rheumatic mitral valve disease

NA

482 (29%)

528 (35%)

1033 (54%)

 < 0.001

Concurrent atrial fibrillation surgery

NA

576 (35%)

674 (45%)

988 (51%)

 < 0.001

Concurrent tricuspid valve repair

NA

463 (28%)

558 (37%)

1048 (55%)

 < 0.001

Infective endocarditis

223 (10%)

187 (9%)

188 (5%)

 < 0.001

26 (2%)

16 (1%)

24 (1%)

0.738

  1. Values are presented as number (%), mean (SD), or median (interquartile range). CABG Coronary artery bypass grafting
  2. *Diagnosed within three months before surgery
  3. During the hospitalisation for surgery